GPR33
geneOn this page
Summary
GPR33 (G protein-coupled receptor 33, HGNC:4489) is a protein-coding gene on chromosome 14q12, encoding Probable G-protein coupled receptor 33 (Q49SQ1). Orphan receptor; could be a chemoattractant receptor.
This gene has been identified as an orphan chemoattractant G-protein-coupled receptors (GPCR) pseudogene. Studies have shown that the inactivated gene is present as the predominant allele in the human population. A small fraction of the human population has been found to harbor an intact allele.
Source: NCBI Gene 2856 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 59 total
- MANE Select transcript:
NM_001197184
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:4489 |
| Approved symbol | GPR33 |
| Name | G protein-coupled receptor 33 |
| Location | 14q12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000214943 |
| Ensembl biotype | protein_coding |
| OMIM | 610118 |
| Entrez | 2856 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000399285
RefSeq mRNA: 1 — MANE Select: NM_001197184
NM_001197184
CCDS: CCDS73628
Canonical transcript exons
ENST00000399285 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001537351 | 31482875 | 31483971 |
| ENSE00003716091 | 31487897 | 31488039 |
Expression profiles
Bgee: expression breadth tissue_specific, 10 present calls, max score 43.10.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0389 / max 10.2286, expressed in 12 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 142746 | 0.0389 | 12 |
Top tissues by expression
122 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| duodenum | UBERON:0002114 | 43.10 | silver quality |
| leukocyte | CL:0000738 | 42.49 | silver quality |
| colonic epithelium | UBERON:0000397 | 42.10 | gold quality |
| vermiform appendix | UBERON:0001154 | 41.92 | gold quality |
| monocyte | CL:0000576 | 41.55 | silver quality |
| lymph node | UBERON:0000029 | 40.54 | gold quality |
| tonsil | UBERON:0002372 | 38.57 | silver quality |
| granulocyte | CL:0000094 | 36.68 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 35.84 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| urinary bladder | UBERON:0001255 | 32.10 | gold quality |
| rectum | UBERON:0001052 | 32.04 | silver quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| endometrium | UBERON:0001295 | 31.68 | gold quality |
| gall bladder | UBERON:0002110 | 31.56 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| liver | UBERON:0002107 | 30.51 | gold quality |
| prefrontal cortex | UBERON:0000451 | 30.07 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 27.58 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.93 | gold quality |
| kidney | UBERON:0002113 | 26.15 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| muscle of leg | UBERON:0001383 | 25.27 | gold quality |
| calcaneal tendon | UBERON:0003701 | 25.20 | gold quality |
| right lobe of liver | UBERON:0001114 | 25.13 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.96 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- Cloning and analysis of more than 120 mammalian GPR33 orthologs from 16 of 18 eutherian orders revealed an inactivation of this chemoattractant GPCR not only in humans, but also in several great ape and rodent species. (PMID:15987686)
- These data indicate an important role of GPR33 function in innate immunity which became dispensable during human evolution most likely due to past or balancing selection. (PMID:20399748)
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Gpr33 | ENSMUSG00000035148 |
Paralogs (8): C5AR2 (ENSG00000134830), GPR32 (ENSG00000142511), FPR2 (ENSG00000171049), FPR1 (ENSG00000171051), C3AR1 (ENSG00000171860), CMKLR1 (ENSG00000174600), FPR3 (ENSG00000187474), C5AR1 (ENSG00000197405)
Protein
Protein identifiers
Probable G-protein coupled receptor 33 — Q49SQ1 (reviewed: Q49SQ1)
All UniProt accessions (1): Q49SQ1
UniProt curated annotations — full annotation on UniProt →
Function. Orphan receptor; could be a chemoattractant receptor.
Subcellular location. Cell membrane.
Tissue specificity. Expressed in spleen, lung, heart, liver, kidney, pancreas, thymus, gonads and leukocytes.
Polymorphism. The sequence shown in this entry differs from the translation of the reference genome assembly (GRCh38/hg38) due to a nonsense variant creating stop codon at position 140 in the reference genome. The sequence shown in this entry is that of variant p.Ter140Arg. This variant has a frequency of about 1% in the human population according to the Genome Aggregation Database (gnomAD v3.1.2). Polymorphic GPR33 gene inactivation has been observed in hominoids, including chimpanzees, as well as in some rodents, such as rat, but not in other mammals. A likely cause of GPR33 inactivation by selection is its interplay with an exogenous factor, such as a rodent-hominoidotopic pathogen.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001184113* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000826 | Formyl_rcpt-rel | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF00001
UniProt features (22 total): topological domain 8, transmembrane region 7, glycosylation site 4, chain 1, disulfide bond 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q49SQ1-F1 | 87.59 | 0.63 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 101–179
Glycosylation sites (4): 5, 12, 19, 272
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 29 (showing top):
GOBP_INFLAMMATORY_RESPONSE, chr14q12, GOBP_REGULATION_OF_IMMUNE_RESPONSE, FOSTER_TOLERANT_MACROPHAGE_DN, GOBP_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, RASHI_RESPONSE_TO_IONIZING_RADIATION_5, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_ACTIVATION_OF_IMMUNE_RESPONSE, GOBP_COMPLEMENT_RECEPTOR_MEDIATED_SIGNALING_PATHWAY, GOBP_IMMUNE_RESPONSE_REGULATING_SIGNALING_PATHWAY, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS, GOMF_COMPLEMENT_RECEPTOR_ACTIVITY, GOMF_IMMUNE_RECEPTOR_ACTIVITY
GO Biological Process (8): complement receptor mediated signaling pathway (GO:0002430), inflammatory response (GO:0006954), phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200), positive regulation of cytosolic calcium ion concentration (GO:0007204), cell communication (GO:0007154), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), signaling (GO:0023052)
GO Molecular Function (2): complement receptor activity (GO:0004875), G protein-coupled receptor activity (GO:0004930)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| G protein-coupled receptor signaling pathway | 2 |
| cellular process | 2 |
| transmembrane signaling receptor activity | 2 |
| immune response-activating cell surface receptor signaling pathway | 1 |
| defense response | 1 |
| phospholipase C activator activity | 1 |
| regulation of biological quality | 1 |
| cell communication | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| regulation of biological process | 1 |
| complement binding | 1 |
| complement receptor mediated signaling pathway | 1 |
| immune receptor activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
394 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GPR33 | DTD2 | Q96FN9 | 570 |
| GPR33 | HEATR5A | Q86XA9 | 478 |
| GPR33 | UNC93A | Q86WB7 | 410 |
| GPR33 | CATSPER2 | Q96P56 | 387 |
| GPR33 | NUBPL | Q8TB37 | 372 |
| GPR33 | GPR148 | Q8TDV2 | 367 |
| GPR33 | GUCY2D | Q02846 | 365 |
| GPR33 | GSTA4 | O15217 | 353 |
| GPR33 | COX6B1 | P14854 | 353 |
| GPR33 | COX6B2 | Q6YFQ2 | 353 |
| GPR33 | ADRA1B | P35368 | 345 |
| GPR33 | KCNE2 | Q9Y6J6 | 325 |
| GPR33 | GPR157 | Q5UAW9 | 320 |
| GPR33 | NBPF14 | Q5TI25 | 310 |
| GPR33 | GPR150 | Q8NGU9 | 307 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A4FUQ5, B9VR26, O08790, O35786, O70129, O75388, O88416, O88536, O88537, O97664, P0C7U4, P21462, P21730, P25089, P25090, P30992, P30993, P33766, P35343, P35407, P46090, P46091, P79175, P79176, P79177, P79178, P79188, P79189, P79190, P79191, P79234, P79235, P79236, P79237, P79240, P79241, P79242, P79243, P97468, P97520
Diamond homologs: A4FUQ5, B1PHQ8, B9VR26, O08565, O08790, O35210, O35786, O62747, O70129, O75388, O77590, O88416, O88536, O88537, O97571, O97664, P0C7U4, P0C7U5, P21462, P21730, P25025, P25089, P25090, P25095, P25104, P28646, P29089, P29754, P29755, P30555, P30556, P30872, P30873, P30937, P30992, P30993, P31391, P33766, P34976, P35373
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
59 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 54 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
92 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:31483969:GACC:G | acceptor_loss | 0.9900 |
| 14:31483970:ACCT:A | acceptor_loss | 0.9900 |
| 14:31483971:CCTG:C | acceptor_loss | 0.9900 |
| 14:31483972:C:CG | acceptor_loss | 0.9900 |
| 14:31483973:T:G | acceptor_loss | 0.9900 |
| 14:31483729:CAT:C | acceptor_gain | 0.9800 |
| 14:31483731:T:TC | acceptor_gain | 0.9800 |
| 14:31483972:C:CC | acceptor_gain | 0.9700 |
| 14:31483968:TGAC:T | acceptor_gain | 0.9600 |
| 14:31487895:ACCTC:A | donor_loss | 0.9500 |
| 14:31487896:C:CA | donor_loss | 0.9500 |
| 14:31487898:TCAG:T | donor_gain | 0.9500 |
| 14:31483987:CAG:C | acceptor_gain | 0.9400 |
| 14:31483731:T:C | acceptor_gain | 0.9200 |
| 14:31483734:T:TC | acceptor_gain | 0.9200 |
| 14:31483979:G:C | acceptor_gain | 0.9200 |
| 14:31483988:A:T | acceptor_gain | 0.9100 |
| 14:31487895:A:AC | donor_gain | 0.9100 |
| 14:31487896:C:CC | donor_gain | 0.9100 |
| 14:31483916:A:AC | donor_gain | 0.9000 |
| 14:31483917:C:CC | donor_gain | 0.9000 |
| 14:31483979:G:GC | acceptor_gain | 0.9000 |
| 14:31487896:CCT:C | donor_gain | 0.8800 |
| 14:31487895:ACCT:A | donor_gain | 0.8700 |
| 14:31487896:CCTC:C | donor_gain | 0.8700 |
| 14:31487897:CTCA:C | donor_gain | 0.8700 |
| 14:31483974:G:GC | acceptor_gain | 0.8600 |
| 14:31483969:GAC:G | acceptor_gain | 0.8500 |
| 14:31483989:G:GC | acceptor_gain | 0.8500 |
| 14:31483734:T:C | acceptor_gain | 0.8400 |
AlphaMissense
2195 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:31483684:C:A | W94C | 0.979 |
| 14:31483684:C:G | W94C | 0.979 |
| 14:31483204:G:C | F254L | 0.977 |
| 14:31483204:G:T | F254L | 0.977 |
| 14:31483206:A:G | F254L | 0.977 |
| 14:31483486:G:C | S160R | 0.976 |
| 14:31483486:G:T | S160R | 0.976 |
| 14:31483488:T:G | S160R | 0.976 |
| 14:31483324:A:C | F214L | 0.975 |
| 14:31483324:A:T | F214L | 0.975 |
| 14:31483326:A:G | F214L | 0.975 |
| 14:31483509:A:G | W153R | 0.968 |
| 14:31483509:A:T | W153R | 0.968 |
| 14:31483839:C:G | G43R | 0.968 |
| 14:31483664:C:G | C101S | 0.967 |
| 14:31483665:A:T | C101S | 0.967 |
| 14:31483838:C:T | G43D | 0.967 |
| 14:31483589:C:G | R126P | 0.965 |
| 14:31483430:C:G | C179S | 0.963 |
| 14:31483431:A:T | C179S | 0.963 |
| 14:31483197:A:G | C257R | 0.960 |
| 14:31483686:A:G | W94R | 0.959 |
| 14:31483686:A:T | W94R | 0.959 |
| 14:31483825:A:C | N47K | 0.958 |
| 14:31483825:A:T | N47K | 0.958 |
| 14:31483599:C:G | G123R | 0.956 |
| 14:31483627:G:C | F113L | 0.956 |
| 14:31483627:G:T | F113L | 0.956 |
| 14:31483629:A:G | F113L | 0.956 |
| 14:31483757:A:G | L70P | 0.955 |
dbSNP variants (sampled 300 via entrez): RS1000037707 (14:31486817 T>C), RS1000410262 (14:31486541 G>A), RS1001187417 (14:31486025 G>A), RS1001456781 (14:31485361 C>T), RS1001849816 (14:31489332 A>C), RS1001901894 (14:31489065 T>C), RS1001994831 (14:31484206 G>A), RS1002193355 (14:31484701 T>C), RS1002330751 (14:31484487 T>A,C), RS1003189939 (14:31483292 T>A), RS1003327329 (14:31482981 C>A,T), RS1003483950 (14:31488965 T>C), RS1003983023 (14:31484427 C>T), RS1004120202 (14:31483957 C>A,G,T), RS1004989921 (14:31482920 C>A,T)
Disease associations
OMIM: gene MIM:610118 | disease phenotypes: MIM:616487
GenCC curated gene-disease
Mondo (1): epidermolysis bullosa simplex with nail dystrophy (MONDO:0014661)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Class A Orphans with no pharmacology
Most potent curated ligand interactions (1 total), top 1:
| Ligand | Action | Affinity | Parameter |
|---|---|---|---|
| cortisol | Binding | 7.92 | pKd |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Targeted by drugs: Hydrocortisone
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): epidermolysis bullosa simplex with nail dystrophy